Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy

Valery Radchenko; Alfred Morgenstern; Amir R. Jalilian; Caterina F. Ramogida; Cathy Cutler; Charlotte Duchemin; Cornelia Hoehr; Ferrid Haddad; Frank Bruchertseifer; Haavar Gausemel; Hua Yang; Joao Alberto Osso; Kohshin Washiyama; Kenneth Czerwinski; Kirsten Leufgen; Marek Pruszyński; Olga Valzdorf; Patrick Causey; Paul Schaffer; Randy Perron; Samsonov Maxim; D. Scott Wilbur; Thierry Stora; Yawen Li

doi:10.2967/jnumed.120.261016

Research ArticleThe State of the Art

Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy

Valery Radchenko, Alfred Morgenstern, Amir R. Jalilian, Caterina F. Ramogida, Cathy Cutler, Charlotte Duchemin, Cornelia Hoehr, Ferrid Haddad, Frank Bruchertseifer, Haavar Gausemel, Hua Yang, Joao Alberto Osso, Kohshin Washiyama, Kenneth Czerwinski, Kirsten Leufgen, Marek Pruszyński, Olga Valzdorf, Patrick Causey, Paul Schaffer, Randy Perron, Samsonov Maxim, D. Scott Wilbur, Thierry Stora and Yawen Li

Journal of Nuclear Medicine November 2021, 62 (11) 1495-1503; DOI: https://doi.org/10.2967/jnumed.120.261016

Valery Radchenko

1Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada;

2Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alfred Morgenstern

3European Commission, Joint Research Centre, Karlsruhe, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amir R. Jalilian

4International Atomic Energy Agency, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Caterina F. Ramogida

1Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada;

5Simon Fraser University, Burnaby, British Columbia, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cathy Cutler

6Collider Accelerator Department, Brookhaven National Laboratory, Upton, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charlotte Duchemin

7CERN, Geneva, Switzerland;

8Institute for Nuclear and Radiation Physics, KU Leuven, Heverlee, Belgium;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cornelia Hoehr

1Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ferrid Haddad

9Arronax, Nantes, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frank Bruchertseifer

3European Commission, Joint Research Centre, Karlsruhe, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Haavar Gausemel

10Bayer American Samoa, Oslo, Norway;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hua Yang

1Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joao Alberto Osso

4International Atomic Energy Agency, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kohshin Washiyama

11Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kenneth Czerwinski

12Radiochemistry Program, Department of Chemistry, University of Nevada, Las Vegas, Nevada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kirsten Leufgen

13SCIPROM Sarl, Saint-Sulpice, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marek Pruszyński

14Institute of Nuclear Chemistry and Technology, Warsaw, Poland;

15NOMATEN Centre of Excellence, National Centre for Nuclear Research, Otwock, Poland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olga Valzdorf

16Isotope JSC, Rosatom State Corp., Moscow, Russian Federation;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patrick Causey

17BWXT Medical Ltd., Ottawa, Ontario, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paul Schaffer

1Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Randy Perron

18Canadian Nuclear Laboratories, Chalk River, Ontario, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samsonov Maxim

19State Scientific Centre of the Russian Federation, Leypunsky Institute for Physics and Power Engineering, Rosatom State Corp., Obninsk, Russian Federation; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

D. Scott Wilbur

20Department of Radiation Oncology, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thierry Stora

7CERN, Geneva, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yawen Li

20Department of Radiation Oncology, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 11

November 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy

Journal of Nuclear Medicine Nov 2021, 62 (11) 1495-1503; DOI: 10.2967/jnumed.120.261016

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy

Journal of Nuclear Medicine Nov 2021, 62 (11) 1495-1503; DOI: 10.2967/jnumed.120.261016

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM
Errata

PubMed
Google Scholar

Cited By...

Is Actinium Really Happening?
Evaluation of Candidate Theranostics for 227Th/89Zr Paired Radioimmunotherapy of Lymphoma
An Experimental Generator for Production of High-Purity 212Pb for Use in Radiopharmaceuticals

Google Scholar

Keywords

targeted α-therapy
production and supply of radionuclides
227Th/223Ra
225Ac/213Bi
211At
212Pb/212Bi

Main menu

User menu

Search

Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords